Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Screening assays for compounds that inhibit membrane fusion-associated events|
|Abstract:||The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP178 (SEQ ID:1) peptide corresponding to amino acids 638 to 673 of the HIV-1.sub.LAI gp41 protein, and fragments, analogs and homologs of DP178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.|
|Inventor(s):||Barney; Shawn O'Lin (Cary, NC), Lambert; Dennis Michael (Cary, NC), Petteway, Jr.; Stephen Robert (Cary, NC)|
|Assignee:||Trimeris, Inc. (Durham, NC)|
|Filing Date:||Sep 26, 1997|
|Claims:||1. A method for identifying peptides that inhibit membrane fusion events comprising: |
(a) the use of a ALLMOTI5, 107.times.178.times.4 or PLZIP computer search motif to identify peptides involved in coiled-coil peptide structures; and
(b) determining whether the identified peptides inhibit cell fusion.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.